DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Teradata Corp
TDC
Collegium Pharmaceutical
COLL
Halozyme Therapeutics
HALO
Hutchmed (China)
HCM
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -55.11%62.21M | 18.04%146.98M | -46.07%104.06M | -16.72%701.11M | 25.69%245.09M | -43.94%138.57M | -62.22%124.51M | 175.07%192.93M | 139.49%841.9M | 11.61%194.99M |
Net income from continuing operations | -51.08%41.77M | -13.87%70.71M | -24.85%136.99M | -25.37%478.63M | 29.32%128.88M | -13.23%85.38M | -72.36%82.09M | 24.63%182.28M | 325.04%641.3M | -28.04%99.65M |
Operating gains losses | ---- | ---- | ---- | 189.36%11.7M | --0 | --11.83M | 104.83%369K | -104.28%-500K | -64.14%4.04M | --0 |
Depreciation and amortization | 7.71%36.64M | 24.88%38.15M | 7.55%40.02M | 10.48%127.36M | -9.66%25.57M | 10.44%34.02M | 0.59%30.55M | 44.25%37.21M | -18.48%115.28M | -28.15%28.31M |
Deferred tax | -170.27%-10.13M | -56.42%3.87M | -89.99%2.91M | -62.72%52.87M | -97.41%508K | -29.08%14.42M | -87.04%8.88M | -12.94%29.06M | 188.83%141.81M | -26.48%19.6M |
Other non cash items | 15.70%1.7M | 12.87%1.69M | 4.39%1.69M | 29.83%6.63M | 575.29%2.04M | -45.88%1.47M | 5.04%1.5M | 16.56%1.62M | -1.20%5.11M | -129.32%-429K |
Change In working capital | 19.58%-8.64M | 896.67%27.52M | -34.55%-86.71M | 106.87%5.72M | 89.60%84.36M | -111.64%-10.75M | 94.64%-3.45M | 58.58%-64.44M | -431.50%-83.25M | 228.92%44.49M |
-Change in receivables | 149.65%30.08M | 2,695.08%30.69M | -88.97%-107.34M | 309.14%46.96M | 131.33%163.25M | -175.90%-60.59M | 103.18%1.1M | 58.94%-56.8M | 46.16%-22.45M | 236.42%70.57M |
-Change in inventory | -159.03%-16.01M | 7.46%-8.24M | -7.15%16.16M | 61.44%-30.79M | -908.18%-66.41M | 728.96%27.13M | 69.80%-8.91M | 144.13%17.41M | -274.74%-79.85M | -124.41%-6.59M |
-Change in prepaid assets | -130.37%-804K | 10,754.55%2.34M | -67.74%-5.27M | -329.05%-2.03M | 80.99%-1.52M | 294.35%2.65M | -100.71%-22K | -143.93%-3.14M | -92.20%888K | -1,052.44%-7.99M |
-Change in payables and accrued expense | -140.12%-8.84M | 280.14%3.9M | 140.30%10.68M | -148.56%-8.43M | 46.30%-4.99M | 5.45%22.03M | 117.63%1.03M | -328.60%-26.5M | 147.22%17.36M | 6.33%-9.29M |
-Change in other working capital | -567.67%-13.07M | -135.11%-1.18M | -120.36%-935K | -98.62%11K | -170.73%-5.98M | 27.99%-1.96M | 48.12%3.35M | 32.68%4.59M | -86.06%798K | -218.47%-2.21M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -55.11%62.21M | 18.04%146.98M | -46.07%104.06M | -16.72%701.11M | 25.69%245.09M | -43.94%138.57M | -62.22%124.51M | 175.07%192.93M | 139.49%841.9M | 11.61%194.99M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -53.54%-172.5M | 17.48%-121.62M | -19.61%-101.69M | -106.63%-527.21M | -85.30%-182.46M | -101.05%-112.35M | -77.77%-147.39M | -375.28%-85.02M | -258.62%-255.14M | -314.99%-98.47M |
Net PPE purchase and sale | -8.78%-115.88M | 18.48%-110.96M | -46.24%-99.7M | -135.54%-491.67M | -112.22%-180.85M | -157.80%-106.53M | -89.91%-136.12M | -547.60%-68.18M | -261.87%-208.74M | -259.17%-85.22M |
Net business purchase and sale | --0 | --0 | --0 | -195.58%-2.42M | --0 | --0 | ---40K | -194.00%-2.38M | --2.53M | --0 |
Net other investing changes | -18.46%-6.9M | 5.09%-10.66M | 86.26%-1.99M | 32.33%-33.11M | 87.91%-1.6M | 60.00%-5.82M | 0.06%-11.23M | -46.14%-14.46M | -263.50%-48.94M | ---13.25M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -53.54%-172.5M | 17.48%-121.62M | -19.61%-101.69M | -106.63%-527.21M | -85.30%-182.46M | -101.05%-112.35M | -77.77%-147.39M | -375.28%-85.02M | -258.62%-255.14M | -314.99%-98.47M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 95.15%-8.09M | 16.82%-10.19M | 37.60%-46.71M | -73.19%-265.18M | 11.53%-11.25M | -84.38%-166.84M | 65.85%-12.25M | -432.92%-74.85M | -58.72%-153.12M | 45.99%-12.72M |
Net issuance payments of debt | 97.64%-3.85M | 46.33%-4.6M | 72.55%-4.29M | -179.20%-194.69M | 23.31%-7.34M | -254.22%-163.15M | -24.18%-8.57M | -117.05%-15.63M | 2.65%-69.73M | -2.47%-9.57M |
Cash dividends paid | -15.08%-4.24M | -51.72%-5.59M | 38.74%-30.64M | 23.33%-61.08M | -17.31%-3.69M | 91.70%-3.69M | 87.27%-3.69M | -1,500.00%-50.02M | -661.98%-79.67M | -20.28%-3.14M |
Net other financing activities | --0 | --0 | -28.04%-11.78M | -152.93%-9.42M | ---221K | --0 | --0 | -147.52%-9.2M | 74.13%-3.72M | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 95.15%-8.09M | 16.82%-10.19M | 37.60%-46.71M | -73.19%-265.18M | 11.53%-11.25M | -84.38%-166.84M | 65.85%-12.25M | -432.92%-74.85M | -58.72%-153.12M | 45.99%-12.72M |
Net cash flow | ||||||||||
Beginning cash position | -14.31%709.02M | -19.56%693.86M | -11.00%738.2M | 109.55%829.48M | -7.89%686.81M | 28.31%827.42M | 98.72%862.55M | 109.55%829.48M | 86.79%395.84M | 177.82%745.67M |
Current changes in cash | 15.81%-118.38M | 143.17%15.17M | -234.08%-44.34M | -121.05%-91.28M | -38.69%51.39M | -239.47%-140.61M | -116.66%-35.13M | -13.45%33.07M | 135.77%433.64M | -34.23%83.81M |
End cash Position | -14.00%590.64M | -14.31%709.02M | -19.56%693.86M | -11.00%738.2M | -11.00%738.2M | -7.89%686.81M | 28.31%827.42M | 98.72%862.55M | 109.55%829.48M | 109.55%829.48M |
Free cash flow | -267.46%-53.67M | 410.31%36.01M | -96.51%4.36M | -66.92%209.43M | -41.48%64.24M | -84.43%32.05M | -104.50%-11.61M | 109.27%124.76M | 115.62%633.16M | -27.29%109.77M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |